Esurgi
  • Home
  • Our Story
  • Our Product
    • The Biostabilizer
    • How to use The Biostabilizer
  • Therapy
    • Patient and Therapist
  • Blog Page
    • Issues
      • Anterior Cruciate Ligament Injury
      • Alzheimer’s Disease
      • Low Back Pain
      • Prescription Support
    • Roles
      • Athletic
      • Medical Officers
      • Physical Therapy / Medicine and Rehabilitation
      • Prescribers
    • Solutions
      • Biostabilizer
      • Joint Spy
      • LeMo
    • Others
  • Contact Us
Select Page

Lower Back Pain: Guideline-Adherent Rehabilitation Lowers Healthcare Utilization

by Felicia Schuessler | Aug 28, 2020 | Biostabilizer, I. Issues, Physical Therapy / Medicine and Rehabilitation

Lower Back Pain (LBP) is the leading global cause of activity limitation and missing work.(6) It is one of the top 15 priority conditions in the United States, and many researchers seek urgently to learn how to reduce the challenge it places on individuals,...

Solutions to Nonspecific Lower Back Pain

by Rachel Borshchenko | Jul 3, 2020 | Biostabilizer, Low Back Pain, Physical Therapy / Medicine and Rehabilitation

Lower back pain (LBP) is an ailment that many people will have to deal with during their lifetime. LBP is one of the leading causes of work-related disability and will be experienced by at least 80 percent of the population at some point.(1) Though in most cases LBP...

Blog Posts

Categories

  • I. Issues
    • Alzheimer's Disease
    • Anterior Cruciate Ligament Injury
    • Genetics
    • Low Back Pain
    • Prescription Support
  • II. Roles
    • Athletic
    • Medical Officers
    • Physical Therapy / Medicine and Rehabilitation
    • Prescribers
  • III. Solutions
    • Biostabilizer
    • Joint Spy
    • LeMo
  • IV. Others

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 2 other subscribers

Recent Comments

    © 2015 - 2020 Esurgi. ALL RIGHTS RESERVED